Table 2.
NIH cGVHD Scores
| NIH Global Score | N (%) | ||
| 1 = mild | 2 (1) | ||
| 2 = moderate | 62 (33) | ||
| 3 = severe | 125 (66) | ||
| NIH Organ Score | N (%) | N (%) | |
| Skin | Liver | ||
| 0 = none | 42 (22) | 0 = none | 91 (48) |
| 1 = mild | 30 (16) | 1 = mild | 64 (34) |
| 2 = moderate | 46 (24) | 2 = moderate | 34 (18) |
| 3 = severe | 71 (38) | 3 = severe | 0 |
| Mouth | Lungs | ||
| 0 = none | 59 (31) | 0 = none | 45 (24) |
| 1 = mild | 104 (55) | 1 = mild | 79 (42) |
| 2 = moderate | 23 (12) | 2 = moderate | 42 (22) |
| 3 = severe | 3 (1.5) | 3 = severe | 23 (12) |
| Eyes | Joints and Fascia | ||
| 0 = none | 33 (17) | 0 = none | 75 (40) |
| 1 = mild | 66 (35) | 1 = mild | 40 (21) |
| 2 = moderate | 69 (36) | 2 = moderate | 55 (29) |
| 3 = severe | 21 (11) | 3 = severe | 19 (10) |
| GI Tract | Genital (female only n= 90) | ||
| 0 = none | 107 (57) | 0 = none | 46 (51) |
| 1 = mild | 62 (33) | 1 = mild | 13 (14) |
| 2 = moderate | 14 (7) | 2 = moderate | 13 (14) |
| 3 = severe | 6 (3) | 3 = severe | 18 (9) |